NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Company Information
About this company
Key people
David A. Rosa
President, Chief Executive Officer, Director
Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Ronald Mcclurg
Chief Financial Officer
Christopher R. Volker
Chief Operating Officer
Steve Mertens
Chief Technology Officer
Emily Johns
General Counsel, Corporate Secretary
Paul Buckman
Independent Chairman of the Board
Jason Mills
Director
Edward Andrle
Independent Director
Jeffrey S. Mathiesen
Independent Director
Click to see more
Key facts
- Shares in issue50.43m
- EPICNMTC
- ISINUS64130M2098
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$45.73m
- Employees18
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.